The left ventricular assist device (LVAD). A bridge to heart transplantation.
Copyright policy )The left ventricular assist device (LVAD). A bridge to heart transplantation.
Since its approval by the USFDA in 1998, the LVAD has been used primarily as a bridge to transplantation. It has been effective in improving the overall health and debilitated states in patients with cardiomyopathies and CHF by restoring them to a near normal hemodynamic state and improving end-organ blood flow. Recent studies indicate that the LVAD might be useful as a destination therapy, making transplantation unnecessary, providing one solution to the imbalance of heart donor supply to transplant candidate need.
- Vanderbilt University Medical Center United States
Heart Failure, Waiting Lists, Contraindications, Health Status, Patient Selection, Decision Trees, Preoperative Care, Heart Transplantation, Humans, Heart-Assist Devices
Heart Failure, Waiting Lists, Contraindications, Health Status, Patient Selection, Decision Trees, Preoperative Care, Heart Transplantation, Humans, Heart-Assist Devices
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!